| 摘要 |
Use of a neurotoxin in the preparation of a pharmaceutical composition for treating neuronally-mediated urologic and related disorders, for example, prostatitis , prostodynia, prostatic enlargement, benign prostatic hyperplasia (BPH) and prostate cancer, are disclosed. |
